The Ali Massumi Cardiac Arrhythmia Symposium 2020

Saturday | February 15, 2020
Best Practices & State-of-the-Art Approaches

Overview

Course Director: Mohammad Saeed, MD

The field of cardiac electrophysiology has evolved from a specialty that primarily managed arrhythmias with drug therapy to one with an expanded role of various nonpharmacologic therapies in detecting and terminating arrhythmias. The Ali Massumi Cardiac Arrhythmia Symposium is designed to provide cardiac electrophysiologists, cardiologists, internists, fellows, cath lab technicians, family and general practitioners and associated professionals with state-of-the-art information on the fundamental mechanisms of cardiac arrhythmias and the best practice approaches to clinical diagnosis, evaluation, and management of abnormal heart rhythms.

Program Overview

The field of cardiac electrophysiology has evolved from a specialty that primarily managed arrhythmias with drug therapy to one with an expanded role of various nonpharmacologic therapies in detecting and terminating arrhythmias. Representative of this development are the rapidly evolving treatment options for patients with ventricular tachycardia and fibrillation (VT/VF), the most common cause of sudden cardiac death. Pharmacotherapy has not proven to be an adequate treatment option for many of these patients. Although implantable cardioverter defibrillators (ICDs) are effective in terminating VT/VF, but repetitive shocks significantly impair quality of life, and inappropriate ICD shocks in patients with heart failure are associated with increased mortality. Percutaneous catheter ablation has evolved as a promising therapy, particularly in patients with recurrent VT refractory to drugs.

There have also been recent changes to the way we manage patients with atrial fibrillation (AF). Guidelines for the use of anticoagulants have been updated and expanded. There are non-pharmacologic therapies now available to prevent embolic stroke in patients who are at increased risk of bleeding. Catheter ablation for AF has become a mainstream treatment option. New catheters with force sensing technology have improved outcomes and reduced complications.

Target Audience

The Ali Massumi Cardiac Arrhythmia Symposium is designed to provide cardiac electrophysiologists, cardiologists, internists, fellows, cath lab technicians, family and general practitioners and associated professionals with state-of-the-art information on the fundamental mechanisms of cardiac arrhythmias and the best practice approaches to clinical diagnosis, evaluation, and management of abnormal heart rhythms.

Faculty

Mohammad Saeed, MD Course Director

Cardiologist and Electrophysiologist, Baylor St. Luke’s Medical Center;
Director, Texas Heart Institute Clinical Cardiac Electrophysiology Fellowship Program at Baylor St. Luke’s Medical Center
Associate Professor, Baylor College of Medicine
(Houston, Texas)

Mehdi Razavi, MD Planning Committee

Director, Electrophysiology Clinical Research & Innovations, Texas Heart Institute
Cardiologist and Electrophysiologist, Baylor St. Luke’s Medical Center
Associate Professor, Baylor College of Medicine
(Houston, Texas)

Abdi Rasekh, MD Planning Committee

Cardiologist and Electrophysiologist, Baylor St. Luke’s Medical Center
Associate Professor, Baylor College of Medicine
Texas Heart Institute Clinical Cardiac Electrophysiology Teaching Staff at Baylor St. Luke’s Medical Center
(Houston, Texas)

Associate Professor
Director of Electrophysiology, Baylor Heart Clinic
Director of Clinical Electrophysiology Research, Baylor College of Medicine
Medical Director, Inherited Arrhythmia and Cardiomyopathy Clinic
Associate Director, Texas Heart Institute Clinical Cardiac Electrophysiology Fellowship at Baylor St. Luke’s Medical Center
(Houston, Texas)

Clinical Assistant Professor, Cardiovascular Surgery and Thoracic Surgery, Baylor College of Medicine
Center for Women’s Heart & Vascular Health, Texas Heart Institute
Surgical Associates of Texas
(Houston, Texas)

Texas Cardiac Arrhythmia
(Austin, Texas)

UT Southwestern Medical Center
(Dallas, Texas)

Cardiologist and Electrophysiologist, Baylor St. Luke’s Medical Center
Assistant Professor, Medicine-Cardiology, Baylor College of Medicine; Houston, Texas
Texas Heart Institute Cardiology Teaching Staff at Baylor St. Luke’s Medical Center
Center for Women’s Heart & Vascular Health, Texas Heart Institute
(Houston, Texas)

Associate Program Director, Residency Program, Baylor College of Medicine at Texas Children’s Hospital
Assistant Professor, Pediatrics / Pediatric Cardiology, Baylor College of Medicine
Texas Heart Institute Cardiology Teaching Staff at Baylor St. Luke’s Medical Center
(Houston, Texas)

Associate Professor, Medicine-Cardiology, Baylor College of Medicine
(Houston, Texas)

Clinical Assistant Professor, Medicine-Cardiology, Baylor College of Medicine
Cardiologist and Electrophysiologist, Baylor St. Luke’s Medical Center and Houston Methodist
Texas Heart Institute Clinical Cardiac Electrophysiology Teaching Staff at Baylor St. Luke’s Medical Center
(Houston, Texas)

Houston Electrophysiology Associates
Texas Heart Institute Cardiology Teaching Staff at Baylor St. Luke’s Medical Center
(Houston, Texas)

Agenda

7:30 am    Registration and Continental Breakfast

8:00     Welcome

Session I | Atrial Fibrillation – A to Z

8:15     Catheter Ablation of AF | Amin Al-Ahmad, MD

8:45     Surgical Ablation of AF | Jennifer Cozart, MD

9:15     Drug and Device Therapy of AF | Abdi Rasekh, MD

9:45     Panel Discussion with Q&A

10:00   Break

Session II | Arrhythmia in Special Population

10:15     Arrhythmias in Athletes | Mark Link, MD

10:45     Arrhythmias in Pregnancy | Joanna Molina-Razavi, MD

11:15     Genetics in Arrhythmia | Mihail Chelu, MD

11:45     EP Jeopardy | Wilson Lam, MD

12:10     Lunch

Session III | Ventricular Arrhythmia

1:15     EP Jeopardy finals | Wilson Lam, MD

1:45     Cardiac Implantable Device Infection | John Seger, MD

2:15     Ventricular Arrhythmias in Heart Failure | Nilesh Mathuria, MD

2:45    Complications of ICD Therapy | Hamid Afshar, MD

3:15     MOC, Closing Remarks and Adjourn

3:45     Adjourn

 

Objectives & Credit Designation

Accreditation

Texas Heart Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

Texas Heart Institute designates this live activity for a maximum of 6.25 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Learning Objectives

At the conclusion of this activity, the participant should be able to:

  • Cite the guidelines for management of AF, including the stroke risk factors, the various treatments to reduce the risk of stroke in patients with non-valvular atrial fibrillation
  • Discuss managing arrhythmia in special populations, including pregnant women, athletes and people with obesity
  • Cite how to improve diagnosis and management of ventricular tachycardia, which may reduce  sudden death and improve patients’ quality of life.
  • Cite the genetic basis of arrhythmia, assessment, prevention, and treatment of these problems.
  • List the complications of ICD therapy, including prevention and management of these incidences.

MOC

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.25 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

 

Meeting Location & Lodging

The Houstonian Hotel
111 North Post Oak Lane
Houston, Texas 77024

The Houstonian Hotel is offering a special conference rate of $199 plus tax, per night. Reservations can be made by calling 713-685-6810 and requesting the Texas Heart Institute rate.